Michael O Sullivan - 16 Dec 2021 Form 4 Insider Report for ORAGENICS INC (OGEN)

Role: Interim PEO, CFO
Signature: /s/ Mark A. Catchur, as Attorney-in-Fact for Michael O. Sullivan
Issuer symbol: OGEN
Transactions as of: 16 Dec 2021
Net transactions value: $0
Form type: 4
Filing time: 17 Dec 2021, 16:13:24 UTC
Next filing: 30 Mar 2022
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	OGEN	Employee Stock Option (Right to Buy)	Award	$0	+150,000		$0.000000	150,000	16 Dec 2021	Common Stock	150,000	$0.4900	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents an annual award of options to purchase shares of the Company's common stock under the Company's 2012 Equity Incentive Plan, as amended that vest evenly in three tranches. One third of the options vest on the first anniversary of the grant date, the second third of the options vest on the second anniversary of the grant date and the final third vest on the third anniversary of the grant date. The option exercise price is the closing price on the date of the grant, December 16, 2021.

Content

Represents an annual award of options to purchase shares of the Company's common stock under the Company's 2012 Equity Incentive Plan, as amended that vest evenly in three tranches. One third of the options vest on the first anniversary of the grant date, the second third of the options vest on the second anniversary of the grant date and the final third vest on the third anniversary of the grant date. The option exercise price is the closing price on the date of the grant, December 16, 2021.